Credit Suisse analyst Karen Short initiates coverage on Best Buy Co (NYSE:BBY) with a Neutral rating and announces Price Target of $90.
Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know
4 analysts have shared their evaluations of Collegium Pharmaceutical (NASDAQ:COLL) during the recent three months, expressing a mix…